US Health Secretary Kennedy distances himself from FDA's Replimune cancer drug rejection - Reuters

Reuters | April 22, 2026, 5:06 p.m. | Original
US Health Secretary Kennedy distances himself from FDA's Replimune cancer drug rejection Reuters
Tesla reports surprise cash surplus in the first quarter - Reuters US CDC will not publish report showing COVID vaccine effectiveness - Reuters